Back to Rankings

INVA

InnovivaC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
INVA vs peer average
59/100
INVA vs. peer average (C vs. D)
Grade spread
B 1 · C 5 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

GILD is the first available peer comparator.

Large-cap biopharma benchmark for cash-flow durability and infectious-disease exposure; useful as a quality reference, but size and mix differ materially.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerGILDGilead Sciences
INVA
Innoviva
GILD
Gilead Sciences
Grade
C
C
Momentum
19
26
Value
71
65
Sentiment
58
51
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs GILD

INVA / GILD
Grade Position
In line
INVA vs. peer average (C vs. D)
59/100
Momentum
19
GILD
Value
71
INVA
Sentiment
58
INVA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs INVA
1
GILD
GILD
C
60/100
Even
2
CAPR
CAPR
C
60/100
Even
3
INBX
INBX
F
20/100
+2
4
MAZE
Maze Therapeutics Inc Common
D
40/100
+1
5
MLTX
MoonLake Immunotherapeutics Class A Common
D
40/100
+1
GILD is the first peer returned for this comparison set.